#latest in oncology

[touchaheartnews]

Five Recent Breakthroughs in the Battle Against Cancer

From combining treatments in unprecedented ways to deploying artificial intelligence for personalised medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology (ESMO), which ends on Tuesday. Here are some of the big announcements made at the five-day conference held in the Spanish city of Barcelona, which brought together 30,000…

[worldpharmatoday]

Eleven early-stage oncology companies join Discovery Spark, a free seven-week development programme at Discovery Park, Sandwich, Kent. For info visit us https://www.worldpharmatoday.com/ , For more info: sunny@worldpharmatoday.com

[drchandrakant01]

Latest Research in Oncology Interventions: What’s New in 2024?

The field of oncology is perpetually evolving, with groundbreaking research and innovative interventions transforming cancer treatment. As we step into 2024, the advancements in oncology are more promising than ever, offering new hope to patients worldwide. This blog explores the latest research in oncology interventions, highlighting significant breakthroughs and their potential impact on cancer care.

Immunotherapy: The Frontier of Cancer Treatment

Immunotherapy continues to be at the forefront of oncology, harnessing the body’s immune system to fight cancer. In 2024, several novel immunotherapy approaches are making waves in cancer treatment.

Personalized Cancer Vaccines: Personalized cancer vaccines are designed to train the immune system to recognize and attack specific cancer cells. Recent studies have shown that these vaccines can induce robust immune responses, particularly in melanoma and lung cancer patients. The vaccines are tailored to individual patients based on the genetic makeup of their tumors, making them highly specific and effective.

Bispecific T-cell Engagers (BiTEs): BiTEs are engineered antibodies that bind to both cancer cells and T-cells, bringing them into close proximity to enhance the immune response against cancer. The latest research indicates that BiTEs are showing promising results in treating hematologic malignancies, such as leukemia and lymphoma, and solid tumors like colorectal and breast cancers.

CAR-T Cell Therapy Enhancements: Chimeric Antigen Receptor T-cell (CAR-T) therapy has been a game-changer for certain types of blood cancers. In 2024, enhancements to CAR-T cell therapy, including the development of allogeneic (off-the-shelf) CAR-T cells and the incorporation of novel targets, are expanding its applicability to a broader range of cancers, including solid tumors.

Precision Medicine: Targeted Therapies Evolving

Precision medicine aims to tailor treatments to the individual characteristics of each patient’s cancer. The latest research in 2024 is pushing the boundaries of targeted therapies.

Liquid Biopsies for Early Detection: Liquid biopsies, which analyze circulating tumor DNA (CTDNA) in the blood, are becoming increasingly sophisticated. Recent advancements have improved their sensitivity and specificity, allowing for earlier detection of cancer and monitoring of treatment response. Liquid biopsies are particularly beneficial for detecting minimal residual disease (MRD) and guiding treatment decisions in real time.

Next-Generation Sequencing (NGS): NGS technology is enabling comprehensive genomic profiling of tumors, identifying actionable mutations and guiding targeted therapy. In 2024, the integration of NGS into clinical practice is more widespread, helping oncologists tailor treatment plans based on the genetic alterations specific to each patient’s cancer. This approach is proving especially effective in treating cancers with rare mutations.

Poly (ADP-ribose) Polymerase (PARP) Inhibitors: PARP inhibitors, initially approved for BRCA-mutated ovarian and breast cancers, are now showing efficacy in other cancer types, including prostate and pancreatic cancers. Research in 2024 is focusing on combining PARP inhibitors with other therapies, such as immunotherapy, to enhance their effectiveness and overcome resistance.

Advances in Radiation Therapy

Radiation therapy remains a cornerstone of cancer treatment, and recent advancements are enhancing its precision and reducing side effects.

Proton Therapy: Proton therapy is a type of radiation that uses protons instead of X-rays to treat cancer. The precision of proton therapy allows for higher doses of radiation to be delivered to tumors while sparing surrounding healthy tissue. In 2024, proton therapy is being utilized more extensively for treating pediatric cancers and tumors located near critical structures, such as the brain and spine.

MR-Linac Systems: Magnetic Resonance Linear Accelerator (MR-Linac) systems combine MRI imaging with linear accelerator radiation delivery, allowing for real-time visualization of tumors during treatment. This technology is improving the accuracy of radiation therapy, particularly for tumors that move with respiration, such as lung and liver cancers.

Stereotactic Body Radiotherapy (SBRT): SBRT delivers highly focused radiation beams to small, well-defined tumors, offering high doses of radiation with minimal impact on surrounding tissues. In 2024, SBRT is being increasingly used for treating oligometastatic disease (limited metastatic tumors) and certain primary cancers, such as early-stage lung cancer and prostate cancer.

Novel Drug Therapies and Combinations

The development of new drugs and combination therapies is accelerating, providing more options for cancer patients.

Antibody-Drug Conjugates (ADCs): ADCs are targeted cancer therapies that deliver cytotoxic drugs directly to cancer cells via monoclonal antibodies. In 2024, new ADCs are showing significant promise in treating various cancers, including breast, bladder, and lung cancers. These therapies are designed to improve efficacy while minimizing systemic toxicity.

Combination Therapies: Combining different treatment modalities, such as immunotherapy with targeted therapy or chemotherapy, is a major focus in oncology research. Recent studies have demonstrated that combination therapies can enhance treatment responses and overcome resistance mechanisms. For instance, combining PD-1/PD-L1 inhibitors with VEGF inhibitors has shown improved outcomes in renal cell carcinoma and hepatocellular carcinoma.

Epigenetic Therapies: Epigenetic therapies, which target the mechanisms that regulate gene expression, are emerging as a promising avenue for cancer treatment. In 2024, researchers are investigating drugs targeting histone deacetylases (HDACs) and DNA methyltransferases (DNMTs) to reverse abnormal gene expression patterns in cancer cells and suppress tumors.

Conclusion

The latest research in oncology interventions in 2024 is paving the way for more effective, personalized, and less toxic cancer treatments. From innovative immunotherapies and precision medicine advancements to cutting-edge radiation techniques and novel drug therapies, the future of cancer care looks brighter than ever. These advancements not only offer new hope for patients but also underscore the importance of ongoing research and collaboration in the fight against cancer. As we continue to unravel the complexities of cancer, the progress made in 2024 brings us one step closer to achieving better outcomes and improving the quality of life for cancer patients worldwide.

[cinnamorollcrybaby]

I want the LaDS boys to react when someone else accidently makes his s/o sexy gasp/moan; someone had randomly poked a spot on her back to get her attention, but it was one of her sensitive spots. Does that make sense? You can write them all or pick one.

Hands off!

Tags: LADS men x fem!Reader, established relationships, jealous LADS men, threats of violence (Rafayel’s) and slight stalking (Caleb’s), suggestive content, NSFW (Sylus’s), MDNI

An: what a wonderfully devious request, i love it.

ZAYNE

The two of you were at a fundraising banquet. The hospital was raising money for pediatric oncology treatment. While Zayne wasn't an oncologist, he made a habit to show his face at most Akso Hospital events, especially ones for a good cause.

You were surrounded by city hall representatives, nurses, doctors, and other big wigs in the healthcare industry. While you felt out of your league, Zayne assured you that he often felt out of place as well, but it was for a good cause at the end of the day.

Giving your temple a light kiss, Zayne follows one of his residents towards the small dessert table that the hospital has set up.

You busy yourself, listening to another doctor's wife prattle on about a recent trip she took to the islands recently. You nurse a glass of champagne to your lips as you're only half listening to her. Inwardly, you wonder when Zayne was going to be back.

“Ah~!” you gasp, face reddening as you jolt slightly. You spin on your heel, looking to see whoever just grazed their hand over your lower back.

You feel you skin grow hot with embarrassment as you see a fellow doctor that Zayne works closely with behind you. He's a little bit older, much old enough to know better than to touch a married woman there. "Oh, I apologize miss. I didn't mean to startle you."

Before you can even think of how to respond, you feel a presence press to your side, and you immediately recognize the smell of your husband's cologne.

"Dr. Hartford, to what do I owe the pleasure?" his stoic voice fills the space, and his hand steadily slides across your lower back until he wraps his palm conspicuously around your hip. It's subtle, but he's staking a claim over you.

"Dr. Zayne! It's so good to see you. I see this must your missus," Dr. Hartford says with a jolly smile. His cheeks and nose are red telling you one of two things: either he's embarrassed to be caught touching you while Zayne was present or he's had far too much alcohol. You decide that it was likely a combination of both factors.

"This is my wife, y/n." Zayne says as his hand imperceptibly tightens around your hip. It's not very often you get to see this more jealous side of him. "For your own benefit, Dr. Hartford, it'd be wise to keep your hands to yourself in the future. You know how... touchy HR can be about these sorts of situations."

Your eyes widen as you look up towards your husband in slight shock and awe. Only Zayne could threaten someone so professionally and look so handsome while doing so.

Now, if only you can convince him to take a few sips of champagne tonight, and you'll have yourself a good night.

RAFAYEL

Being a Lemurian meant that every one of his senses is attuned to be able to experience his beloved better. This meant he practically heard your small moan before it ever even left your lips.

His eyes search the crowd at the art exhibit he was forced to attend. You promised to stay by his side, but where were you now?

To the average person’s eye, Rafayel looks completely normal right now. Someone would even say he seems aloof, but to the people who truly know him, he’s seething with an unforeseen anger.

Once his eyes zero in on you and Thomas of all people, Rafayel feels his anger only double. He doesn’t even excuse himself away from the group of people that were talking and interviewing him about his latest painting. He walks over straight to you.

“You know, it’s not nice to touch things that aren’t yours,” he says, throwing a quick glare over at Thomas. His voice sounded lighthearted, almost like he was some petulant child who caught someone playing with his favorite toy, but you knew the truth.

Thomas’s face was already beet red. When he grabbed your side to stabilize himself, he didn’t think you were going to make that noise. He also didn’t consider that Rafayel would hear it.

You look towards your boyfriend, who is nearly pouting at you from the whole exchange, and you playfully roll your eyes. “Thomas was just trying to keep his balance. He didn’t mean anything by it.”

“Well, if my girlfriend was standing beside me, then Thomas could’ve grabbed someone else’s girlfriend, bur no, he had to grab mine,” Rafayel huffed as he turned his nose up at the two of you, putting on a show of bratty behavior.

“You’re so helpless, Rafayel.” You tease, looping your arm around his to follow him back to his painting.

“Only for you, miss bodyguard.” He then reached out a hand and drops a piece of paper onto Thomas’s extended hand. “That’s for you.”

Thomas waited until the two of you were a distance away before he slowly unfolded the small piece of paper. His eyebrows furrowed as he read the words on the paper.

I’ll kill you and paint with your remains xD

Stunned, Thomas looked back up to where you and Rafayel were. His eyebrows furrowed a little bit, wondering if Rafayel was just playing or not…

XAVIER

The moment a sharp breathy moan leaves your lips while you, Xavier, and another Hunter are out on the field, you know one thing is certain. Xavier's going to kill him.

His hand is still wrapped around your waist. He had only grabbed you to protect you from stepping in a puddle on your way towards reported wanderer activity.

Unfortunately for this poor hunter, who you thought was actually named Hunter, your waist was where you were most sensitive.

Xavier immediately spun around, and his light blade was out within milliseconds. His sapphire blue eyes narrowed as he saw where Hunter was grasping you. His jaw tightens, and you can immediately perceive the stormy look on his face.

“Hands off her,” the blonde hunter demanded. “She’s fine. She can handle herself.”

“Right— I was just.. helping her out, man. No harm; no foul,” the other hunter said as he took his hands off of you. He held his palms facing Xavier in a surrendering position.

No one in the UNICORNS knew about yours and Xavier’s budding relationship, but they were going to find out real quickly if Xavier’s jealousy kept getting the better of him.

“Y/n, you should lead,” Xavier says, ignoring Hunter’s statement. He puts you in the front of their small group, and he trails right behind you, leaving Hunter in the back.

While your back is turned, your boyfriend casually pointed his light blade towards Hunter, forcing space between him and the group. He then shot a glare that could kill over his shoulder to Hunter.

The intention was clear. Xavier was posturing. His glare said all the unspoken words that he could not. ‘Stay away. This is mine.’

The poor man didn’t even speak to you for the rest of the mission. He was way too intimidated by Xavier to even consider it. Oh well, Xavier would just have to keep you company.

SYLUS The two of you were at a couple’s massage. Well, you were getting a massage, and he got to watch with a glass of wine on the side.

When the masseuse’s fingers rubbed into your neck, targeting all the knots from stress and tension, a breathy little whimper escaped your throat.

Sylus was already having a hard enough time concealing just how much of an effect you had on him. His right ankle was propped against his left knee, and he was settled back onto the chair.

He let out a deep, rich laugh that only men with old money seemed to have.

You were clearly embarrassed, clenching your eyes shut as you profusely apologized. The masseuse tried to reassure you that it was natural, and it only meant she was doing a good job.

“Careful kitten, if you stress yourself out anymore, you’re going to need a massage for this massage,” he teased, swirling his wine glass in his glass cup.

“Oh no, that would be sooo terrible,” you responded back with sarcasm bitten into your tone.

“We all know you’re having a good time, kitten. No need to rub it in everyone’s faces.” A smirk curled on his lips as his roamed over your body, only covered with a towel.

“Shut it-!” you whined, feeling the embarrassment creep back in.

He was doing a good job at hiding it, but his pants felt extremely tight. The thought of you letting out those delicate sounds accidentally, so overwhelmed by painful pleasure…

He took another sip of his wine, and he eyed the masseuse closely. He had gotten massages from her in the past. He knew she was happily married, and he had nothing to worry about. Even if the masseuse was some single guy, he would’ve still been comfortable in his position. He knows you’re not going anywhere; he trusts you with his entire being.

Still, he watched extra closely. He now felt the need to learn how to use his hands like that. The next time you got a massage, he wanted to be the one to make you let out those noises. He also wanted to be in private, so he could bury his cock into you in peace.

CALEB

Oh, oh man… First of all, when you and Caleb first started dating, he barely let you out of arm’s length of his side. He couldn’t help it. He needed you there with him :(

However, when he finally started letting both of you do things on your own, he still had a habit of watching you.

You were going to go get drinks with a girl friend? Oh okay, that’s fine… the bar has cameras anyway :)

You needed to go to the grocery store? Caleb’s already hacked into their security system. No big deal.

You wanted to go out for a walk? Sure, Caleb would just walk a good enough distance behind you so you didn’t see him, which is exactly what was happening when he heard that small whine..

He knows that whine by heart. Hell, he’s been teasing you for years, but he’s only heard that specific whine when he’s rearranging your guts.

Subtlety be damned. He didn’t care about staying incognito whenever there was someone else who just got to hear that very, very sweet noise from your lips.

When he jogs straight up to you, he’s nearly panting but not from jogging — his pissed. The guy who had gotten you to make that noise was profusely apologizing for accidentally pulling your hair. Apparently, he saw a bug on you or something…

It didn’t matter to Caleb. Of course, he was polite, putting on a good show by laughing and teasing you. He ignored the confused looks that you threw his way.

“Yep, my girlfriend is so unaware, haha. Thanks for getting that bug off her. She hates those things,” he flashes that pretty smile that’s gotten him out of trouble for years.

While guiding you away from the man, he assures you that he was just going the same way as you because he needed to run to the market really quick for a very specific ingredient for what he was making for dinner tonight.

And of course, the kind stranger was never heard from again. If you have any information on the missing man, please contact the local authorities or the Deepspace Aviation Administration. 

[thewitfire]

Latest Cancer Cure News 2023: Advances in Oncology

Latest Cancer Cure News 2023: Advances in Oncology. #cancernews #latestcancernews #oncology #pharmanews

Latest Cancer Cure News 2023: As we progress through 2023, the field of oncology continues to witness groundbreaking advancements that are reshaping the landscape of cancer treatment. These developments not only offer new hope to patients worldwide but also signify the relentless efforts of the scientific community in their quest to conquer cancer. This article delves into some of the most…

[market-insider]

AI-Powered Analytical Solutions for Oncology: The Next Step in Cancer Research

The global AI in oncology for analytical solutions market size is expected to reach USD 7.4 billion by 2030. The increasing demand to reduce healthcare costs is expected to be a crucial factor driving the adoption of artificial intelligence (AI) in oncology for analytical solutions. The implementation of artificial intelligence algorithms in oncology can significantly improve the accuracy of procedures and reduce the costs associated with treatment by avoiding unnecessary tests. For instance, a June 2021 study published in Frontiers found that incorporating artificial intelligence in the diagnosis of colorectal cancer helped save around USD 400 million, primarily due to the early detection of cancer.

Gain deeper insights on the market and receive your free copy with TOC now @: AI In Oncology For Analytical Solutions Market Report

The high prevalence of cancer-related diseases worldwide is expected to drive the expansion during the forecast period. For example, the American Cancer Society, Inc. estimates that by the end of 2022, there will be nearly 1.9 million new diagnoses and 609,360 cancer-related deaths in the U.S. Additionally, lung, breast, rectal, and colon cancers were the most common cancers in February 2022, according to the World Health Organization. Moreover, a third of global cancer deaths are attributed to high body mass index, tobacco use, and lack of physical activity. Therefore, the increasing prevalence of this disease globally is expected to increase the adoption of artificial intelligence for more accurate diagnosis, contributing to the growth of the AI in oncology analytical solutions market.

The market is anticipated to grow due to improvements in healthcare infrastructure and the increasing prevalence of cancer. By utilizing artificial intelligence technology, healthcare providers can diagnose and plan treatment procedures with greater ease. The use of artificial intelligence enables earlier and more accurate detection, reducing treatment costs and enhancing the patient experience through personalized treatment. Additionally, the growth is fueled by initiatives from government and non-government organizations that invest in healthcare R&D. For instance, the Indian government plans to introduce healthcare infrastructure programs worth USD 6.8 billion, according to a recent report from IBEF.

[odinsblog]

UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ten or more, according to findings from the Federal Trade Commission.

The report, which levels the same allegations at CVS and Cigna, is the latest indictment of America’s broken healthcare system and comes on the heels of last month’s shocking murder of UnitedHealthcare CEO Brian Thompson.

The U.S. is notorious for incurring the highest costs per capita of any wealthy nation, yet failing to achieve an even remotely equivalent improvement in patient outcomes versus Europe’s social market-based economies.

Critics argue that is due largely to the highly opaque manner in which needless markups are hidden to conceal inefficiencies that serve various vested interests. These include, but are not limited to, the big three drug middlemen known as pharmacy benefit managers (PBMs).

According to the FTC report, UnitedHealth’s OptumRx, along with Cigna’s Express Scripts and CVS Caremark Rx, were able to collectively pocket $7.3 billion in added revenue above cost during the five year period of the study through 2022.

“The Big 3 PBMs marked up numerous specialty generic drugs dispensed at their affiliated pharmacies by thousands of percent, and many others by hundreds of percent,” it concluded.

A thousand percent increase in the price of a drug that costs $10 wholesale would result in a retail price of $110.

This markup rate applied to 22% of the specialty therapies examined, including Imatinib, a generic used to treat leukemia, or non-oncological Tadalafil for pulmonary hypertension. Others such as Lamivudine needed by HIV-positive patients were nearly quadruple the price of their acquisition cost.

Independent Vermont Sen. Bernie Sanders has been conducting Congressional hearings in an attempt to shed light on the problems posed by these drug middlemen as well as drugmakers themselves.

(continue reading)

[featherwurm]

Oh hey I meant to post this on my birthday but I made it to 40 - considering the cancer* and stuff I'm pretty damn pleased! Hoping for several decades more but taking it bit by bit, yanno, one oncology appointment at at time and all that (latest one went well, just got another CT scan for a baseline while I'm well, forgot how tiring those can be but they are kinda neat).

*I was diagnosed at 35.

[progenitorensis]

Dr Wesker, do you have a favorite flower?

Sonnentreppe. It's Sonnentreppe, obviously, genetically imprinted in his finest design, a flower transcending its' temporary nature that cycled between death and rebirth and brought the same unto those that consumed it, but Albert Wesker can't say that.

It's an odd question at this 'convention' from the scientist sitting across from him - but it's not unconscionable, given the circumstances he and several others find themselves in, baited into a company-wide trap of socialization to discuss the latest in key speakers' research.

Research he has no personal, vested interest in save for its' finale, too confidential to be comfortable discussion at this mockery of a round-table. Much of the genetics research that has yet to debut results is soon to unveil.

He sits up farther, adjusting the hem of the grey-white lab coat that falls just above his knees, telltale lack-of expression adorned upon his visage. This room is full of lighter colors from various units; genetics, neurology, oncology, mutagenesis...

For him to be asked first implies an eagerness for an answer, and from that eagerness it seems the man finds himself a fan of his prior studies (it can be surmised, the way the whitecoat leans into his space most obnoxiously, brows that just barely avoid cinching). Wesker doesn't quite recall his name, pushed out of mind to take note of more worthy details passed from loose lips.

Part of him wants the attention. Craves recognition - the scent of approval. This man will feed him well & truly - he can say almost anything to garner it.

So... he pretends to give it thought, head tilting upward something self-aggrandizing as his fingers steeple in search of not-entirely-dishonest. A crumb. "I am quite enthused by Leontopodium." He pauses.

A man shuffles his papers in the background, electing to clear a parched throat.

"Pharmacophore screening has... potential." He clicks a pen idly, up, down, up, down.

"Leoligin interests me greatly." It's a potent CETP agonist that would be useful to offset initial dyslipidemia in primary Progenitor infection, maybe decrease intimal hyperplasia of venous bypass grafts in outstanding patients - the latter of which hadn't quite been necessary in humanoid subjects for some time.

Those who required such a graft from Uroboros infection usually faced rejection as it was, unfit ticking time bombs for whom the method of expulsion was yet to be refined.

They were set to be expunged, not worth resources save for further study if cases emerged new, favorable mutations.

Of those who didn't face rejection, most were animal bases or their batch derived from T, where cardiomyopathy was a common side-effect even in successful infection.

It was that first hurdle that often lead to fatal SCD, he'd theorized. Higher compatibility could be achieved with intravenous Leoligin, excellent toxicology results in tow.

Wesker's head bobs to the side, shades trained on his target while a presentation on something-or-other flashes by. How useful can this man be? Can he curry favor by pretending he takes interest in a reply? "What are your thoughts?"

[xieyaohuan]

A month ago, when I went to hospital on suspicion of sepsis, one of my blood tests returned a value that was really low. In fact, it was "off" by so much that I was convinced it had to be wrong. I became even more convinced when I learned these errors are apparently common for this particular blood value, especially if you use a certain method. My doctor decided to take another blood sample with a different method "just to be sure". That's what we did yesterday.

This morning, as I was getting ready to go to the airport to catch a flight, I got a call from my doctor's office. I told them I had to get to the airport or I would miss my flight. Could it not wait for a week or two? They told me to skip the flight and come in.

So I did.

They called me into the doctor's office pretty much right away. Turns out the value was slightly better than the last time but still much too low. I told them I had to fly out by next week at the latest or I'd miss the conference I was organizing. (Yes, I realized, even as I was saying this, that my priorities were a little misplaced, but I guess it felt better to think about work than about whatever health news I'd just got.) The doctor told me if the value was just a little lower, he'd have to bar me from flying, but it wasn't, so it was my decision.

I told the doctor I didn't think this test was correct. If it was real, I'd be bleeding out of my eyes. The doctor said he wasn't sure and gave me a referral to a hematologist, which I guess most of the time is just a more gentle way of giving a patient a referral to an oncologist.

So then I was back out on the street, thinking about how I had promised my mom an update on the blood test. (I usually keep my parents out of any health business, but I had visited them after the fake-sepsis hospital incident and couldn't really hide what had happened since I was still on antibiotics. And, well, once my mom is involved, she's involved.)

I still think the result is incorrect. And to be fair, even a false positive on the diagnosis the doctor gave me can apparently also be due to cancer and all other kinds of nasty health issues. But overall, it seems vastly preferable.

Anyway, now I've been procrastinating all day on making an appointment at the hematologist, simply because all hematology clinics also have the word "oncology" in their name. It's too late now, but I guess I'll try and make an appointment tomorrow morning.

Right now, I'm mainly trying to figure out why my brain has switched from "always convinced I'm somehow dying" to "stupidly optimistic bordering on insanity" mode. It's fascinating. Like, I have genuinely convinced myself the test is wrong and I'll be fine, when, based on how my brain usually works, I should be freaking out. Because even if I'm right, there's more than a non-zero chance that I'm not, and normally that alone would probably give me a panic attack.

[thelovelymissbigbadwolf]

Still thinking about Nurse/Dr Fair and since I'm a sucker for him undeniably being drawn to tragedy I'm making oncologist Fair au

Decided to cure cancer when he was 9 and his favorite relative died

Studied as hard as he could, BARELY passing on medicine on Shinra, like, BY A SINGLE POINT

He studied even harder now that he had his ADHD diagnosis and watched Patch Addams and got heavily inspired

Was planning on just being general surgeon, but watched House and liked Wilson, so he decided to follow a old dream of his

Became a resident at the ripe age of 23, VERY young, yes.

Spent a few years on residence until he finally got to follow on oncology

His first case was a old man with stage four lung cancer.

He passed away from a aneurysm, Zack was understandably devastated by it, but didn't let that get him down.

Later in his career, he got his youngest case, a new born

It progressed very quickly and the baby couldn't make it, unfortunately

He had to take a while off after it, a weekend with friends and family helped him lots

He goes to every single one of his patient's funeral and makes sure to cover all burial expenses for the family.

Latest in his life, he was casually chatting with a friend who had a really bad stomach ache (you can guess who it is) and he told him to get it checked just in case

A few days later, his newest case arrived. Stage four gastric cancer, patient name: Cloud Strife.

[drgopalsharmasblog]

Expert in Medical Oncology (Breast, Thoracic, Gynaecology) – Dr Gopal Sharma

When it comes to cancer treatment in India, patients look for trusted, experienced, and compassionate specialists. One of the most respected names in the field of Medical Oncology (Breast, Thoracic, Gynaecology) is Dr Gopal Sharma, who offers advanced, patient-centered care across a range of cancer types.

With years of experience in treating breast, lung (thoracic), and gynecological cancers, Dr Gopal Sharma is widely recognized for his evidence-based treatments and successful outcomes.

About Dr Gopal Sharma

Dr Gopal Sharma is a leading medical oncologist in India, known for his exceptional work in the field of Medical Oncology (Breast, Thoracic, Gynaecology). With a strong educational background and international exposure, he brings global standards of care to his cancer patients.

He specializes in:

Breast Cancer Treatment

Lung and Thoracic Cancer Management

Gynaecological Cancer Therapy

Whether you're looking for a second opinion, an advanced treatment option, or compassionate care during your cancer journey, Dr Gopal Sharma stands by your side with integrity and medical excellence.

Specialization in Medical Oncology (Breast, Thoracic, Gynaecology)

Breast Cancer

Breast cancer is one of the most prevalent cancers affecting women worldwide. Dr Gopal Sharma follows a personalized approach to breast cancer treatment based on:

Tumor size, type, and receptor status (HER2, ER, PR)

Use of targeted therapy, chemotherapy, hormonal therapy

Pre- and post-surgical cancer management

With deep expertise in Medical Oncology (Breast, Thoracic, Gynaecology), he ensures patients receive the latest and most effective therapies available.

Thoracic (Lung) Cancer

Lung cancer is often diagnosed late, making expert intervention critical. As a specialist in Medical Oncology (Breast, Thoracic, Gynaecology), Dr Gopal Sharma offers:

Immunotherapy and precision medicine

Targeted therapy for EGFR, ALK, and ROS1 mutations

Chemotherapy combinations suited for non-small cell and small cell lung cancer

His experience in thoracic oncology helps improve survival rates and enhance patient quality of life.

Gynaecological Cancers

Gynecologic cancers like cervical, ovarian, and endometrial cancer require a unique and compassionate approach. Dr Gopal Sharma coordinates with expert surgeons and radiologists to deliver:

Optimal staging and diagnosis

Advanced chemotherapy and hormone therapy

Molecular profiling and risk-based treatment planning

Women undergoing treatment under Dr Gopal Sharma find comfort and trust in his in-depth understanding of Medical Oncology (Breast, Thoracic, Gynaecology).

Why Choose Dr Gopal Sharma?

Here’s why patients across India trust Dr Gopal Sharma for cancer care:

Expertise in Medical Oncology (Breast, Thoracic, Gynaecology) Customized Treatment Plans Based on Latest Global Protocols Highly Rated Cancer Specialist with Compassionate Care Strong Track Record of Successful Cancer Outcomes

Whether it’s breast cancer, lung cancer, or gynecological tumors, you receive full-spectrum care with updated technology and patient-first protocols.

Patient Testimonials

“When I was diagnosed with breast cancer, I was lost. Dr Gopal Sharma gave me hope, explained every step, and treated me with dignity. Thanks to him, I’m now cancer-free and stronger than ever.”

“Dr Sharma’s team helped me through chemotherapy for ovarian cancer. I never felt alone. His understanding of Medical Oncology (Breast, Thoracic, Gynaecology) gave me

Book an Appointment

Take the first step toward expert cancer care today. If you or a loved one need treatment for breast, thoracic, or gynecologic cancer, consult Dr Gopal Sharma—a name you can trust in Medical Oncology (Breast, Thoracic, Gynaecology).

👉 Contact Now:  Visit our official clinic or website  Call for appointments  https://drgopalsharma.co.in/

[silverleafclinic]

About

Advanced Surgical care at Silver Leaf Hospital

At Silver Leaf Hospital Diagnostic Clinic, we are committed to providing a holistic approach to healthcare with a wide range of advanced diagnostic services tailored to your needs. Our state-of-the-art facilities include MRI scans for detailed imaging, CT scans for precise cross-sectional views, and high-resolution ultrasounds for real-time assessments of soft tissues and organs. We also offer comprehensive mammography services using the latest digital breast tomosynthesis technology for early breast cancer detection. With cutting-edge technology and a patient-centered approach, we ensure accurate and timely diagnoses for better health outcomes.

Dr. Vinod Gore: Pioneering Cancer & Robotic Surgeon in Pune

Renowned for his exceptional surgical skills and compassionate approach, Dr. Vinod Gore is a leading Surgical Oncologist with over 20 years of experience in the field. Based in Pune, India, Dr. Gore has dedicated his career to delivering outstanding patient care and advancing the field of oncology.

Cutting-Edge Expertise

Dr. Gore is a master of innovative surgical techniques, including:

 Robotic Oncosurgery

Thyroid and Endocrine Surgery

Lung and Thoracic Surgery

Breast Surgery

Colorectal Surgery

Dedicated to Giving Back

Dr. Gore is passionate about anti-tobacco awareness and advocacy. He serves as Patron for Voice of Tobacco Victims Maharashtra, working tirelessly to promote public health and well-being.

Trailblazing Achievements

Awarded “Best Robotic Cancer Surgeon” by Navbharaga Times

Recognized as “Trailblazing Indian Oncocare Leader” by The Economic Times

Introduced Electrochemotherapy in Asia in 2013, a groundbreaking treatment modality.

Advancing Cancer Care through Research and Innovation

Dr. Gore is committed to staying at the forefront of cancer treatment. He has adopted cutting-edge technologies like Robotic Surgery, AI, and Fluorescence-Guided Surgeries to ensure optimal patient outcomes.

Founder and Director of Silver Leaf Clinic

Under Dr. Gore’s visionary leadership, Silver Leaf Clinic has become a beacon of ho.pe for patients seeking comprehensive cancer care.

[bbmct]

BBMCT: Embark on Medical Research at AIIMS Hospital

Clinical research plays a pivotal role in advancing medical science, improving patient care, and bringing innovative therapies to market. British Biomedicine Clinical Trials (BBMCT) at AIIMS Hospital offers an invaluable opportunity to be part of groundbreaking research in the healthcare field. Known for its prestigious reputation, robust facilities, and ethical approach, BBMCT is a trusted partner for clinical trials. In this blog, we will explore how BBMCT at AIIMS Hospital is revolutionizing medical research with its world-class resources, experienced researchers, and ethical commitment.

## Prestigious Institution for Clinical Research

AIIMS Hospital, India’s premier medical institution, has long been recognized as a leader in clinical research. Established in 1956, AIIMS has become synonymous with high-quality healthcare and research excellence. BBMCT leverages this prestigious legacy, offering researchers and patients access to a facility that is both globally recognized and locally impactful.

The institution is renowned for its research in diverse medical fields, ranging from oncology to neurology, pediatrics to cardiology. Its affiliation with the government ensures significant funding and support for clinical research, making it an ideal setting for conducting advanced trials. Whether for early-phase studies or large-scale trials, BBMCT provides a dependable platform for research excellence.

## Access to a Varied Patient Demographic

One of the key advantages of conducting clinical trials at AIIMS Hospital is the institution’s access to a wide and varied patient demographic. Located in the heart of India’s capital, AIIMS draws patients from across the country and beyond. This diverse population provides invaluable insights into how treatments and therapies work across different genetic backgrounds, socioeconomic statuses, and health conditions.

BBMCT at AIIMS can effectively conduct research across a wide range of diseases, ensuring that clinical trial data is comprehensive, robust, and reflective of global health trends. Researchers can rely on this broad patient base for better generalizability of trial outcomes, making their findings highly applicable to diverse patient populations.

## Cutting-Edge Research Facilities at Your Disposal

AIIMS Hospital is equipped with state-of-the-art research facilities that are at the forefront of medical innovation. From advanced diagnostic laboratories to high-tech imaging centers, BBMCT at AIIMS ensures that clinical trials are conducted under the best possible conditions. The hospital’s cutting-edge infrastructure includes sophisticated equipment for monitoring patient responses, analyzing data, and providing precise outcomes.

AIIMS also hosts specialized centers of excellence in areas like cancer research, cardiology, and neurosciences, ensuring that BBMCT has access to the latest research tools and methodologies. This focus on high-quality facilities provides a solid foundation for successful clinical trials, enabling researchers to make well-informed, evidence-based conclusions.

## Knowledgeable Researchers Deliver Reliable Outcomes

At the heart of every successful clinical trial is a team of knowledgeable and skilled researchers. BBMCT at AIIMS benefits from a team of experienced professionals who are experts in their respective fields. The institution attracts top-tier medical practitioners, scientists, and researchers who are committed to pushing the boundaries of medical knowledge.

AIIMS Hospital fosters a collaborative environment, encouraging cross-disciplinary research that ensures comprehensive, reliable outcomes. Researchers are well-versed in both the scientific and regulatory aspects of clinical trials, allowing them to design and execute studies that meet international standards while producing valid, reproducible results. This expertise significantly enhances the credibility of trials conducted under BBMCT.

## Firm Commitment to Ethical Research Standards

BBMCT at AIIMS Hospital places a strong emphasis on ethical standards in clinical research. The institution is committed to ensuring that patient rights, safety, and well-being are prioritized at all times. Strict adherence to ethical guidelines is ensured through institutional review boards (IRBs), regular audits, and continuous monitoring throughout the trial process.

The institution follows established ethical guidelines such as the Declaration of Helsinki and Good Clinical Practice (GCP), ensuring that trials meet international standards. By upholding these ethical standards, BBMCT builds trust with patients, researchers, and regulatory bodies, contributing to the reliability and legitimacy of the research conducted.

## Strong Support for Regulatory Compliance

Navigating the complex landscape of regulatory compliance is one of the critical components of conducting clinical research. BBMCT at AIIMS Hospital offers robust support in ensuring that all clinical trials comply with both Indian and international regulatory requirements. The research team is well-versed in guidelines set by regulatory bodies like the Drugs Controller General of India (DCGI) and the World Health Organization (WHO).

AIIMS Hospital’s research department has a dedicated team to assist in preparing, submitting, and reviewing clinical trial protocols to meet regulatory standards. This strong focus on compliance ensures that trials proceed smoothly without legal or procedural obstacles, fostering a trustworthy environment for all stakeholders involved.

## Efficient Management of Trial Execution

The execution of clinical trials requires careful planning, organization, and real-time management. BBMCT at AIIMS excels in the efficient management of trial execution, from recruitment to monitoring and reporting. The institution’s infrastructure, experienced staff, and technological tools help streamline trial processes, ensuring timelines are met and patient safety is maintained throughout.

BBMCT utilizes advanced project management software and patient monitoring tools to ensure trials are executed with precision. This attention to detail and structured management approach increases the likelihood of successful trial outcomes, providing timely and accurate data that can influence future medical practices and treatments.

## Established Success Record in Trials

BBMCT has built a solid track record of success in clinical trials over the years. With numerous trials completed successfully, the institution has gained recognition for its commitment to research excellence and its ability to deliver dependable results. This history of success has attracted global pharmaceutical companies, biotech firms, and research organizations to collaborate with BBMCT at AIIMS Hospital.

The success of BBMCT can be attributed to the institution’s rigorous trial methodologies, advanced technologies, and highly skilled teams. These factors combined have resulted in impactful clinical research, often leading to the development of new drugs, therapies, and medical procedures that improve patient outcomes globally.

/media/88de57a97f470a96a9071d7d2f030cba

## FAQs About BBMCT at AIIMS Hospital

**1. What makes BBMCT at AIIMS a trusted partner for clinical trials?**

BBMCT at AIIMS Hospital is trusted due to its prestigious standing, cutting-edge research facilities, and experienced team of researchers. The institution adheres to the highest ethical and regulatory standards, ensuring that trials are conducted safely and effectively. Its ability to recruit a diverse patient population further enhances the reliability and applicability of trial outcomes, making it a trusted partner for advanced clinical research.

**2. How does AIIMS Hospital support patient safety during clinical trials?**

AIIMS Hospital prioritizes patient safety through rigorous monitoring, ethical protocols, and regular audits by Institutional Review Boards (IRBs). Strict adherence to Good Clinical Practice (GCP) guidelines ensures that patient welfare is safeguarded throughout the trial process. Additionally, patients are fully informed about the potential risks and benefits before consenting to participate, ensuring that their rights are upheld.

**3. What regulatory bodies oversee clinical trials at BBMCT?**

Clinical trials conducted at BBMCT at AIIMS are overseen by several regulatory bodies, including the Drugs Controller General of India (DCGI) and the World Health Organization (WHO). These organizations set the framework for regulatory compliance and ensure that clinical trials meet international safety and ethical standards.

**4. What types of clinical trials are conducted at BBMCT?**

BBMCT at AIIMS conducts a wide range of clinical trials, including Phase I-IV studies in fields such as oncology, cardiology, neurology, and infectious diseases. The trials may involve testing new drugs, therapies, diagnostic methods, or medical devices, and can be designed to explore safety, efficacy, or the optimal dosage of treatments.

**5. Can international companies partner with BBMCT for clinical research?**

Yes, BBMCT at AIIMS welcomes partnerships with international pharmaceutical companies, biotech firms, and research organizations. The institution’s reputation for high-quality research, access to a diverse patient base, and advanced facilities make it an attractive partner for global clinical trials.

## Conclusion

British Biomedicine Clinical Trials (BBMCT) at AIIMS Hospital provides a unique and prestigious platform for conducting advanced clinical research. With its world-class research facilities, experienced teams, diverse patient base, and unwavering commitment to ethical practices, BBMCT is paving the way for the future of medical science. The institution’s strong regulatory compliance, efficient trial management, and successful track record make it a leading choice for both national and international clinical research partnerships. For those seeking to embark on medical research, BBMCT at AIIMS Hospital is undoubtedly the trusted partner for innovation and success in the healthcare industry.

Subscribe to BBMCLINICALTRIALS YouTube channel for Research Insights

Be sure to subscribe to the **BBMCLINICALTRIALS YouTube channel** for exclusive access to the latest updates and in-depth insights into British Biomedicine Clinical Trials (BBMCT). Stay informed on cutting-edge research, clinical trial advancements, patient safety protocols, and breakthrough therapies being tested at AIIMS Hospital. Our channel provides expert discussions, industry trends, and detailed videos on the clinical trial process across various therapeutic areas. Whether you’re a healthcare professional, researcher, or simply interested in biomedical innovation, subscribing will keep you at the forefront of clinical research developments. Don’t miss out — join our community today!

[thewitfire]

Latest Cancer Cure News 2023: Breakthroughs in Oncology

Latest Cancer Cure News 2023: Breakthroughs in Oncology. #cancernews #LatestCancerCureNews2023

Latest Cancer Cure News 2023: The year 2023 has been a landmark year in the field of oncology, witnessing several groundbreaking advancements in cancer research and treatment. These developments offer new hope and expanded treatment options for patients battling various forms of cancer. This article delves into some of the most significant breakthroughs that have emerged this year, marking a new…

[tomorrowusa]

Trump's pal Vladimir Putin is back to bombing children's hospitals in Ukraine. Putin can't understand why Ukrainians won't let him take over their country. So he's killing as many of their children as possible as retribution.

Russian missile strike partially destroyed a children’s hospital in Kyiv on Monday, causing terrified patients and their families to flee for their lives, as officials fear more people could be trapped beneath the rubble. Moscow launched a brazen daytime aerial assault on targets in cities across Ukraine during morning rush hour, killing at least 36 people and injuring 137 others, according to Ukraine’s emergency service. The large scale bombardment struck areas in the capital, as well as in Dnipro, Kryvyi Rih, Slovyansk and Kramatorsk. In an update on Telegram, the emergency service said the latest figure included the number of dead and injured in the capital, which now stands at 22 people killed. Two people were killed and at least 16 were injured in the strike on Kyiv’s Okhmatdyt hospital. The facility is Ukraine’s largest children’s medical center and has been vital in the care of some of the sickest children from across the country. Every year, around 7,000 surgeries – including treatments for cancer and hematological diseases – are conducted at the hospital, according to Ukraine’s human rights ombudsman Dmytro Lubinets. Videos from the scene showed volunteers working with police and security services to sift through the rubble as smoke billowed from the hospital, as staff described how they tried to rush children to safety in the wake of the attack. Ukraine’s health minister Viktor Liashko said intensive care units, oncology departments and surgery units had been damaged.

US Republicans and others from the radical right around the world back Putin. They bizarrely see him as "strong" despite the incompetent way he's conducted his war and the enormous losses Russia has sustained.

To give you a ground level view of how Russia is actually doing in its shabby unprovoked war, the Washington Post published intercepts of communications by Russian troops during their failed Kharkiv offensive.

Russian ground troops are poorly trained, poorly armed, and poorly supplied. Putin just mindlessly throws troops at Ukraine the way Trump throws ketchup at walls.

The Russian population is kept ignorant of massive losses and is fed histrionic nationalistic propaganda on state TV. Internet access to Western news sites blocked. Putin mouthpieces dressed like James Bond villains openly promote additional war crimes.

Russia is not a normal country and it is not led by a normal person.

Despite what tankies and far right Putin apologists may tell you, Russia has no fucking business in Ukraine.